TY - JOUR
T1 - Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysis
AU - Hamaki, T.
AU - Katori, H.
AU - Kami, T.
AU - Yamato, T.
AU - Yamakado, H.
AU - Itoh, T.
AU - Kusumi, E.
AU - Igarshi, M.
AU - Ueyama, J.
AU - Kanda, Y.
AU - Miyakoshi, S.
AU - Mineishi, S.
AU - Morinaga, S.
AU - Mukai, M.
AU - Hayashi, M.
AU - Takaue, Y.
AU - Hara, S.
AU - Mutou, Y.
PY - 2002
Y1 - 2002
N2 - A 27-year-old man with aplastic anemia and renal insufficiency requiring dialysis underwent allogeneic PBSCT. The preparative regimen consisted of melphalan, ATG and TLI. GVHD prophylaxis consisted of cyclosporine and prednisolone. He was dialyzed prior to administration of melphalan and at 24 and 72 h after it. Otherwise, the dialysis schedule was unchanged, at three times a week. Engraftment was rapid. Regimen-related toxicity was minimal. Pharmacokinetic parameters of melphalan were not significantly altered with its plasma half-life 1.5 h. Patients with renal failure can receive, allogeneic HSCT, and a combination of melphalan, ATG and TLI may serve as an alternative to CY and ATG.
AB - A 27-year-old man with aplastic anemia and renal insufficiency requiring dialysis underwent allogeneic PBSCT. The preparative regimen consisted of melphalan, ATG and TLI. GVHD prophylaxis consisted of cyclosporine and prednisolone. He was dialyzed prior to administration of melphalan and at 24 and 72 h after it. Otherwise, the dialysis schedule was unchanged, at three times a week. Engraftment was rapid. Regimen-related toxicity was minimal. Pharmacokinetic parameters of melphalan were not significantly altered with its plasma half-life 1.5 h. Patients with renal failure can receive, allogeneic HSCT, and a combination of melphalan, ATG and TLI may serve as an alternative to CY and ATG.
UR - http://www.scopus.com/inward/record.url?scp=19044369008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19044369008&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1703584
DO - 10.1038/sj.bmt.1703584
M3 - Article
C2 - 12189539
AN - SCOPUS:19044369008
SN - 0268-3369
VL - 30
SP - 195
EP - 198
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 3
ER -